CBR1 Recombinant Antibody, FITC Conjugated
Product Specifications
Background
NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol.
Synonyms
CBR1; CRN; SDR21C1.
Gene ID
873
Swiss Prot
P16152
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
CBR1
Clonality
Recombinant
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human CBR1
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Product Datasheet
https://www.biossantibodies.com/datasheets/bsm-61366R-FITC
Gene ID URL
873
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1061237-01 0.02 mg (E-Coli)
Recombinant Shewanella woodyi 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA)
Ask
View Details MBS1061237-02 0.02 mg (Yeast)
Recombinant Shewanella woodyi 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA)
Ask
View Details MBS1061237-03 0.1 mg (E-Coli)
Recombinant Shewanella woodyi 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA)
Ask
View Details MBS1061237-04 0.1 mg (Yeast)
Recombinant Shewanella woodyi 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA)
Ask
View Details